Eli Lilly And reported $17.12B in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 19322M 802M
Astrazeneca AZN:US 20.92B 1.73B
AstraZeneca AZN:LN 20.92B 1.73B
Baxter International BAX:US $ 7882M 291M
Biogen BIIB:US $ 9740.9M 1825M
Bristol Myers Squibb BMY:US $ 30186M 65M
Catalent CTLT:US $ 2916M 109M
Coherus Biosciences CHRS:US $ 446.78M 65.66M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Gilead Sciences GILD:US $ 13705M 1076M
Glaxosmithkline GSK:US $ 54188M 25200M
GlaxoSmithKline GSK:LN 5418.8B 2520B
Horizon Pharma HZNP:US $ 3203.09M 255.36M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Lannett LCI:US $ 290.12M 28.59M
Medtronic MDT:US $ 22135M 924M
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NOVN:VX 38.14B 906M
Novartis NVS:US $ 38142M 906M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Phibro Animal Health PAHC:US $ 566.23M 19.76M
Prestige Brands PBH:US $ 324.62M 31.35M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
United Therapeutics UTHR:US $ 2684.3M 97.7M
Zoetis ZTS:US $ 6651M 186M